Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas,

Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced quite a bit. But there are some signs to watch for — and a new test to identify prostate cancer.

Thousands more men are having checks for prostate cancer since Sir Chris Hoy revealed he had been diagnosed with the disease and was terminally ill.

The House Committee on Oversight and Government Reform has expanded its investigation of the cover-up of former President Joe Biden’s health, prostate cancer, and mental decline. On June 4, Chairman James Comer subpoenaed five former senior White House aides to appear for transcribed interviews in addition to Biden’s physician,

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a placebo-controlled trial involving men with non-metastatic HSPC. Denosumab outperformed zoledronic acid for preventing SREs in men with metastatic castration-resistant prostate cancer.

Prostate cancer is the most common form of cancer among men in England, with cases surging among both men and women by 25 per cent between 2019 and 2023 according to NHS data. It’s also the second deadliest form of the disease for men after lung cancer,

Researchers have found in a new BARCODE1 study that a polygenic risk score identified a higher proportion of clinically significant prostate cancer compared to PSA or MRI screening, which